Semin Plast Surg 2017; 31(01): 040-045
DOI: 10.1055/s-0037-1598192
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Orbital Decompression for Thyroid Eye Disease

Tara L. Braun
1   Division of Ophthalmology, Baylor College of Medicine, Houston, Texas
,
Mohin A. Bhadkamkar
1   Division of Ophthalmology, Baylor College of Medicine, Houston, Texas
,
Kevin T. Jubbal
1   Division of Ophthalmology, Baylor College of Medicine, Houston, Texas
,
Adam C. Weber
1   Division of Ophthalmology, Baylor College of Medicine, Houston, Texas
,
Douglas P. Marx
1   Division of Ophthalmology, Baylor College of Medicine, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
28 February 2017 (online)

Preview

Abstract

Although most cases of thyroid eye disease (TED) can be managed medically, some refractory or severe cases are treated surgically with orbital decompression. Due to a lack of randomized controlled trials comparing surgical techniques for orbital decompression, none have been deemed superior. Thus, each case of TED is managed based on patient characteristics and surgeon experience. Surgical considerations include the extent of bony wall removal, the surgical approach, the choice of incision, and the use of fat decompression. Outcomes vary based on surgical indications and techniques; hence, vision can improve or worsen after the surgery.